Stay updated with breaking news from Share Rights Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The board of directors for Hansa Biopharma AB (publ) has today resolved to issue 850,769 new class C shares and to immediately thereafter...
/PRNewswire/ -- The board of directors for Hansa Biopharma AB (publ) has today resolved to issue 850,769 new class C shares and to immediately thereafter...
/PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, has today on June 30,...
Share this article Share this article LUND, Sweden, April 9, 2021 /PRNewswire/ -- Hansa Biopharma AB (publ), Reg. No. 556734-5359, with registered office in Lund, gives notice to Annual General Meeting on Wednesday May 12, 2021. In order to mitigate the spread of Covid-19, the Board of Directors has decided that the Annual General Meeting will be conducted by advance voting only, without physical presence of shareholders, proxies and third parties. Hansa Biopharma welcomes all shareholders to exercise their voting rights at this Annual General Meeting through advance voting on the basis of te...